Moleculin Biotech, Inc. Cumulative Translation Adjustment, Net of Tax, Period Increase (Decrease)
Moleculin Biotech, Inc. (MBRX) reported Cumulative Translation Adjustment, Net of Tax, Period Increase (Decrease) of $25.00 thousand for the 3-month period ending 2020-06-30, per its 10-Q filed 2020-08-12.
Discontinued › Notes
us-gaap:CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease · last filed 2020-08-12
- Moleculin Biotech, Inc. cumulative translation adjustment, net of tax, period increase (decrease) for the quarter ending 2020-06-30 was $25.00K.
- Moleculin Biotech, Inc. cumulative translation adjustment, net of tax, period increase (decrease) for the quarter ending 2020-03-31 was -$33.00K.
- Moleculin Biotech, Inc. cumulative translation adjustment, net of tax, period increase (decrease) for the quarter ending 2019-09-30 was -$3.00K, a 120.00% decline year-over-year.
- Moleculin Biotech, Inc. cumulative translation adjustment, net of tax, period increase (decrease) for the quarter ending 2019-06-30 was -$2.00K, a 133.33% decline year-over-year.
- Moleculin Biotech, Inc. cumulative translation adjustment, net of tax, period increase (decrease) for fiscal 2019 was -$4.00K, a 111.43% decline from fiscal 2018.
- Moleculin Biotech, Inc. cumulative translation adjustment, net of tax, period increase (decrease) for fiscal 2018 was $35.00K.
| Period end | Cumulative Translation Adjustment, Net of Tax, Period Increase (Decrease) 3 month | Cumulative Translation Adjustment, Net of Tax, Period Increase (Decrease) 6 month | Cumulative Translation Adjustment, Net of Tax, Period Increase (Decrease) 9 month | Cumulative Translation Adjustment, Net of Tax, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2020-06-30 | $25.00K 10-Q · filed 2020-08-12 | -$8.00K derived: sum of 2 quarters · filed 2020-08-12 | ||
| 2020-03-31 | -$33.00K 10-Q · filed 2020-08-12 | |||
| 2019-12-31 | -$4.00K 10-K · filed 2020-03-19 | |||
| 2019-09-30 | -$3.00K 10-Q · filed 2019-11-12 | -$5.00K derived: sum of 2 quarters · filed 2020-08-12 | -$16.00K derived: sum of 3 quarters · filed 2020-08-12 | |
| 2019-06-30 | -$2.00K 10-Q · filed 2020-08-12 | -$13.00K derived: sum of 2 quarters · filed 2020-08-12 | ||
| 2019-03-31 | -$11.00K 10-Q · filed 2020-08-12 | |||
| 2018-12-31 | $35.00K 10-K · filed 2020-03-19 | |||
| 2018-09-30 | $15.00K 10-Q · filed 2019-11-12 | $21.00K derived: sum of 2 quarters · filed 2019-11-12 | ||
| 2018-06-30 | $6.00K 10-Q · filed 2019-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |